INVESTMENT IN TNF PHARMACEUTICALS, INC. (Details - Preferred stock) |
6 Months Ended |
|---|---|
|
Oct. 31, 2024
USD ($)
| |
| MyMD Preferred Stock [Member] | |
| Marketable Securities [Line Items] | |
| Fair value of financial assets at beginning | $ 0 |
| Fair value of investment, purchases | 17,410,050 |
| Change in fair value of investment | 1,388,950 |
| Fair value of financial assets at ending | 18,799,000 |
| MyMD Preferred Stock Warrants [Member] | |
| Marketable Securities [Line Items] | |
| Fair value of financial assets at beginning | 0 |
| Fair value of investment, purchases | 10,985,684 |
| Change in fair value of investment | (4,929,684) |
| Fair value of financial assets at ending | $ 6,056,000 |
| X | ||||||||||
- Definition Fair value portion of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|